International Generics & Biosimilar Medicines Association (IGBA), Austria
Member of the IGBA Biosimilars Committee
Dr. Thomas Kirchlechner holds a Master’s degree in chemistry from the University of Munich, Germany, and a PhD in chemistry, specializing in marine analytics, from Otago University in Dunedin, New Zealand. In total, he has accumulated 23 years of vast experience in the pharmaceutical industry, including Global Biopharmaceutical Regulatory Affairs at Sandoz in Austria for the last 20 years. His current role is in Biosimilars Regulatory Policy & Intelligence, and he is based in Kundl, Austria. Thomas is member of the International Generics & Biosimilar Medicines Association (IGBA) Biosimilar Committee.